Pancreatic Cancer Research

ReviewWorld J Gastrointest Oncol2018

Shattering the castle walls: Anti-stromal therapy for pancreatic cancer.

Journal
World J Gastrointest Oncol
Published
1 August 2018
Citations
28
Type
Review
License
cc by-nc

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract cc by-nc

Despite the availability of potent chemotherapy regimens, such as 5-fluorouracil, folinic acid, irinotecan, and oxaliplatin (FOLFIRINOX) and nab-paclitaxel plus gemcitabine, treatment outcomes in metastatic pancreatic cancer (PC) remain unsatisfactory. The presence of an abundant fibrous stroma in PC is considered a crucial factor for its unfavorable condition. … Excerpt only: this text is the publisher’s. Read it in full at the source.